DBVT · Nasdaq, OTC · CIK 0001613780
DBV Technologies S.A.
DBV Technologies S.A.’s most recent SEC filing in our snapshot is a Form 8-K filed on Sep 30, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $5.6M and net income of -$146.9M, according to its XBRL data on EDGAR. Its EDGAR record lists 8 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- DBV Technologies S.A.
- Tickers
- DBVT, DBVTF
- SEC Central Index Key (CIK)
- 0001613780
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) (code 2836)
- Business address
- CHATILLON
- State or country of incorporation
- France
- Fiscal year ends
- December 31
- SEC filer category
- Non-accelerated filer<br>Smaller reporting company
- Position in SEC ticker list
- #2782 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from DBV Technologies S.A.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.7M | $4.8M | $15.7M | $4.2M | $5.6M |
| Net income | -$97.8M | $96.3M | $72.7M | -$113.9M | -$146.9M |
| Diluted EPS | -$1.78 | -$1.24 | -$0.76 | -$1.17 | -$1.05 |
| Total assets | $146.7M | $246.5M | $183.0M | $65.7M | $233.7M |
| Cash and equivalents | $77.3M | $209.2M | $141.4M | $32.5M | $194.2M |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Mar 26, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Jul 16, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Sep 30, 2026 | 8-K | Other events· period Sep 29, 2026 | Document · Index |
| May 11, 2026 | DEF 14A | Definitive proxy statement· period Jun 3, 2026 | Document · Index |
| Mar 20, 2020 | 20-F | Annual report of a foreign private issuer· period Dec 31, 2019 | Document · Index |
| Dec 28, 2020 | 6-K | Report of a foreign private issuer· period Jun 30, 2020 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about DBV Technologies S.A., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Sep 30, 2026 | 8-K | Other events· period Sep 29, 2026 | Document · Index |
| Aug 14, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 6, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Jul 31, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 29, 2026 | Document · Index |
| Jul 27, 2026 | S-3ASR | Simplified registration statement | Document · Index |
| Jul 16, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Jul 16, 2026 | 8-K | Results of operations· period Jul 16, 2026 | Document · Index |
| Jun 29, 2026 | 8-K | Other events· period Jun 29, 2026 | Document · Index |
| Jun 5, 2026 | 8-K | Director or officer change· period Jun 3, 2026 | Document · Index |
| Jun 4, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| Jun 3, 2026 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results· period Jun 3, 2026 | Document · Index |
| May 15, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 12, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 11, 2026 | ARS | ARS· period Dec 31, 2025 | Document · Index |
| May 11, 2026 | DEF 14A | Definitive proxy statement· period Jun 3, 2026 | Document · Index |
| May 5, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 5, 2026 | 8-K | Director or officer change· period Apr 30, 2026 | Document · Index |
| May 4, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| May 1, 2026 | PRE 14A | PRE 14A· period Jun 3, 2026 | Document · Index |
| Apr 30, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| Apr 30, 2026 | 8-K | Results of operations· period Apr 30, 2026 | Document · Index |
| Apr 30, 2026 | 10-K/A | Amended annual report· period Dec 31, 2025 | Document · Index |
| Apr 16, 2026 | 3 | Initial statement of beneficial ownership· period Oct 30, 2025 | Document · Index |
| Mar 26, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Mar 26, 2026 | 8-K | Results of operations· period Mar 26, 2026 | Document · Index |
| Mar 2, 2026 | 8-K | Other events· period Feb 28, 2026 | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 3, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 29, 2026 | Document · Index |
| Jan 20, 2026 | 8-K | Other events· period Jan 16, 2026 | Document · Index |
| Jan 14, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 12, 2026 | Document · Index |
| Jan 14, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Jan 8, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Jan 7, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
Insider filing activity
8 Form 4 filings appear in DBV Technologies S.A.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Biological Products, (No Diagnostic Substances)
- AMGN AMGEN INC
- GILD GILEAD SCIENCES, INC.
- MRNA Moderna, Inc.
- ARGX ARGENX SE
- RVMD Revolution Medicines, Inc.
- BIIB BIOGEN INC.
- BNTX BioNTech SE
- EXEL EXELIXIS, INC.
All 61 companies in Biological Products, (No Diagnostic Substances)
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001613780 and XBRL company facts. DBV Technologies S.A. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement